Pasithea Therapeutics Corp.
KTTA
$1.23
$0.042.94%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/2/2025
-
TipRanks Financial Blog
12/2/2025
-
Globe Newswire
12/2/2025
-
MarketBeat
12/1/2025
-
MarketBeat
12/1/2025
-
MarketBeat
12/1/2025
-
Ticker Report
12/1/2025
-
Market Exclusive
11/30/2025
-
MarketBeat
11/30/2025
-
MarketBeat
11/30/2025
-
MarketBeat
11/29/2025
-
MarketBeat
11/29/2025
-
MarketBeat
11/28/2025
-
MarketBeat
11/28/2025
-
Nasdaq News: Markets
11/28/2025
-
GuruFocus
11/28/2025
-
The Fly
11/28/2025
-
Globe Newswire
11/27/2025
-
MarketBeat
11/27/2025
-
TipRanks Financial Blog
11/27/2025
-
Stocktwits News Feed
11/25/2025
-
TipRanks Financial Blog
11/25/2025
-
GuruFocus
11/25/2025
-
TipRanks Financial Blog
11/25/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
786 977 3380
Address
1111 Lincoln Road
Miami Beach, FL 33139
Miami Beach, FL 33139
Country
Year Founded
Business Description
Sector
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and...
more